biotechValue proposition
Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients.
Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products.
Calliditas Therapeutics AB
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
https://www.calliditas.se/en/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 1 Dec 2021 | ||
 Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 2 Feb 2021 | ||
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Not capitalistic Not partnership Event 15 Nov 2022 19 Nov 2022 | ||
| Axis | Entities | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| No similarities | |||||||||
We're proud to sponsor American Association of Kidney Patients' webinar on Jan. 31, 3:00-4:00 pm ET, titled "A Treatment Specifically Designed for IgA Nephropathy, an AAKP HealthLine Innovator Webinar." Accessible to anyone interested in learning about #IgAN. Register here: https://bit.ly/3YqgKD6
Meet the #CalliditasCommunity! A pioneer in the industry, Teona Pipiya Johnson, Head of U.S. Marketing, is passionate about communicating treatment options through accessible platforms to patients affected by diseases with high unmet needs. More about our team: https://bit.ly/3hBn3Qa
Our office dog Lilly is the center of attention wearing a cozy sweater, enjoying some fresh air—and she knows it! After all, she’s a VIP (very important pet) at the office, where team members fawn over her as she does her job dutifully. Stay tuned to learn more about our team!
We're proud to sponsor American Association of Kidney Patients' webinar, where Jonathan Barratt will share insights on #IgANephropathy & a treatment specifically designed for this #RareDisease. Available to anyone interested in learning more about #IgAN, register now: https://lnkd.in/egwd4F8N
Living with a chronic #autoimmune disease such as #IgANephropathy can be overwhelming. IgAN Connect is a great resource for learning approaches to management, finding treatment options, and ways to live with and navigate #IgAN. Explore #IgANconnect here: https://bit.ly/3MmuCYD